Grow your business safely with REXPHARM

All the information you need about REXPHARM to develop and secure your business in France

R HOME > CORPORATES > REXPHARM > BALANCE SHEET ( 2022-11-03)

THE LIST OF BALANCE SHEET : REXPHARM

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-11-03 Public 2022-03-31 Complete
2021-10-27 Public 2021-03-31 Complete
2021-01-27 Public 2020-03-31 Complete
2019-09-13 Public 2019-03-31 Complete
2018-08-08 Public 2018-03-31 Complete
2017-06-21 Public 2016-12-31 Complete
NameREXPHARM
Siren811569946
Closing2022-03-31
Registry code 9201
Registration number 54305
Management number2015B03994
Activity code 7022Z
Closing date n-12021-03-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2022-11-03
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address92310 SEVRES
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BJ TOTAL (I) 7.00 7.00 7.00
BX Customers and related accounts 8.00 8.00 8.00
BZ Other receivables 50 686.00 50 686.00 50 686.00
CJ TOTAL (II) 50 694.00 50 694.00 50 694.00
CO Grand total (0 to V) 50 701.00 50 701.00 50 701.00
CU Other investments 7.00 7.00 7.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 50 000.00 50 000.00 50 000.00
DH Retained earnings -2 394.00 -2 519.00 -2 394.00
DI RESULTS FOR THE YEAR (Profit or Loss) 696.00 124.00 696.00
DL TOTAL (I) 48 301.00 47 605.00 48 301.00
DX Trade payables and related accounts 2 400.00 2 400.00 2 400.00
EC TOTAL (IV) 2 400.00 2 400.00 2 400.00
EE Grand total (I to V) 50 701.00 50 005.00 50 701.00
EG Accrued income and payables due within one year 2 400.00 2 400.00 2 400.00
EK (including equity difference) 2.00 2.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FQ Other income 3 219.00
FR Total operating income (I) 3 219.00
FW Other purchases and external expenses 2 622.00
GF Total Operating Expenses (II) 2 622.00
GG - OPERATING RESULT (I - II) 597.00
GJ Financial income from other securities and fixed asset receivables 1.00
GK Income from other securities and fixed asset receivables 97.00
GP Total financial income (V) 98.00
GV - FINANCIAL INCOME (V - VI) 98.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 696.00
4 - Income statement (continued)Amount year NAmount year N-1
HL TOTAL REVENUE (I + III + V + VII) 3 318.00 3 147.00 3 318.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 2 622.00 3 022.00 2 622.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 696.00 124.00 696.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 7.00 7.00
I3 DECREASES Total Financial Fixed Assets 7.00
I4 DECREASES Grand Total 7.00
LQ ACQUISITIONS Total Financial Fixed Assets 7.00 7.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 2 400.00 2 400.00 2 400.00
UX Other trade receivables 8.00 8.00 8.00
VC Group and associates 50 686.00 50 686.00 50 686.00
VT TOTAL – STATEMENT OF RECEIVABLES 50 694.00 50 694.00 50 694.00
VY TOTAL – STATEMENT OF LIABILITIES 2 400.00 2 400.00 2 400.00

all companies in France

Complete and comprehensive database.